Gut Microbiome Changes Indicate Parkinson’s Risk
Alterations in the gut microbiome can identify individuals at elevated risk of Parkinson’s disease well before symptoms manifest, according to recent research that also offers potential avenues for new treatments.
Scientists have identified distinctive changes in the gut microbial community that are more evident in people with a genetic predisposition to Parkinson’s and become even more pronounced in those diagnosed with the condition.
This microbial signature could enable clinicians to detect patients at risk years prior to the onset of overt symptoms and suggests that interventions such as healthier diets and therapies targeting the microbiome might prevent or delay disease development.
Study Insights and Expert Commentary
Professor Anthony Schapira, head of clinical and movement neurosciences at University College London and lead author of the study, noted this is the first instance where a microbial signature associated with Parkinson’s has been observed in individuals genetically susceptible but asymptomatic. The signature appears to intensify as the disease advances.
“These same changes can be found in a small proportion of the general population that may put them at increased risk,” Schapira said.
Parkinson’s Disease Overview
Parkinson’s cases have doubled over the past 25 years, with over 8.5 million people worldwide currently living with the disease. Parkinson’s causes progressive neurological damage, resulting in tremors, slowed movement, muscle stiffness, and rigidity. Patients frequently experience depression, anxiety, sleep disturbances, memory issues, and balance difficulties.
The disease is characterized by the death of neurons in the substantia nigra region of the brain, leading to decreased dopamine levels, which underlie many symptoms. While there is no cure, treatments such as dopamine-enhancing medications, physiotherapy, and surgical options can alleviate symptoms.
Research Methodology and Findings
The UCL research team analyzed clinical and fecal data from 271 Parkinson’s patients, 43 individuals carrying a Parkinson’s risk gene but without symptoms, and 150 healthy controls.
They found that the abundance of over 25% of gut microbial species—176 in total—differed significantly between Parkinson’s patients and healthy individuals. These microbial alterations were not attributable to medication effects. A similar microbial pattern was observed in genetically predisposed but asymptomatic participants.
The findings were validated using additional clinical data from 638 Parkinson’s patients and 319 healthy controls across the UK, South Korea, and Turkey. A subset of healthy individuals exhibited the microbiome signature, indicating potential risk for Parkinson’s.
Potential Mechanisms Linking Microbiome and Parkinson’s
It remains unclear whether the microbial signature contributes to Parkinson’s onset or results from the disease, or if both processes occur. Professor Schapira suggested that microbiome changes might influence production of alpha-synuclein, a protein implicated in neuronal damage in Parkinson’s.
“Certain bacteria cause inflammation in the gut wall that increases alpha-synuclein, which is then transported up the vagus nerve from the gut to the brain and then into the brain cells affected in Parkinson’s,” he explained. The vagus nerve transmits signals between the brain and major organs.
Implications for Treatment and Lifestyle
Further research and clinical trials are necessary to clarify how gut microbes relate to Parkinson’s and whether modifying the microbiome could offer protection. However, dietary changes may be beneficial. The study noted that individuals with the abnormal microbiome signature consumed more processed foods and saturated fats, while eating fewer fruits, vegetables, fiber-rich foods, fish, and lentils.
Expert Perspectives on the Findings
Claire Bale, associate director of research at Parkinson’s UK, emphasized the study’s contribution to mounting evidence on the gut microbiome’s role in Parkinson’s.
“The findings indicate that changes in the microbiome may occur in the very early stages of the condition and that the extent of these changes may correlate with disease progression,” she said.
“Over the past decade, we have seen the impact of physical activity on managing symptoms and potentially slowing the course of the condition. Our growing understanding of the gut microbiome offers similar hope that dietary modification could benefit those living with Parkinson’s.”
